{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:37:56Z","timestamp":1790059076124,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Checkpoint kinase 1 (CHK1) is critical for intrinsic cell cycle control and coordination of cell cycle progression in response to DNA damage. Despite its essential function, CHK1 has been identified as a target to kill cancer cells and studies using <jats:italic>Chk1<\/jats:italic> haploinsufficient mice initially suggested a role as tumor suppressor. Here, we report on the key role of CHK1 in normal B-cell development, lymphomagenesis and cell survival. Chemical CHK1 inhibition induces BCL2-regulated apoptosis in primary as well as malignant B-cells and CHK1 expression levels control the timing of lymphomagenesis in mice. Moreover, total ablation of <jats:italic>Chk1<\/jats:italic> in B-cells arrests their development at the pro-B cell stage, a block that, surprisingly, cannot be overcome by inhibition of mitochondrial apoptosis, as cell cycle arrest is initiated as an alternative fate to limit the spread of damaged DNA. Our findings define CHK1 as essential in B-cell development and potent target to treat blood cancer.<\/jats:p>","DOI":"10.1038\/s41467-017-01850-4","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T17:36:11Z","timestamp":1510853771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis"],"prefix":"10.1038","volume":"8","author":[{"given":"Fabian","family":"Schuler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke E.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lohm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-1087","authenticated-orcid":false,"given":"Simon F.","family":"Spiegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-4470","authenticated-orcid":false,"given":"Philipp","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Geley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Labi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Villunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"1850_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cell.2015.08.006","volume":"162","author":"RC Burgess","year":"2015","unstructured":"Burgess, R. C. & Misteli, T. Not all DDRs are created equal: non-canonical DNA damage responses. Cell \n                           162, 944\u2013947 (2015).","journal-title":"Cell"},{"key":"1850_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ijc.28226","volume":"134","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. & Hunter, T. Roles of Chk1 in cell biology and cancer therapy. Int. J. Cancer \n                           134, 1013\u20131023 (2014).","journal-title":"Int. J. Cancer"},{"key":"1850_CR3","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1101\/gad.840500","volume":"14","author":"Q Liu","year":"2000","unstructured":"Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)\/M DNA damage checkpoint. Genes Dev. \n                           14, 1448\u20131459 (2000).","journal-title":"Genes Dev."},{"key":"1850_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1126\/science.288.5470.1425","volume":"288","author":"N Mailand","year":"2000","unstructured":"Mailand, N. et al. Rapid destruction of human Cdc25A in response to DNA damage. Science \n                           288, 1425\u20131429 (2000).","journal-title":"Science"},{"key":"1850_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/emboj\/16.3.545","volume":"16","author":"MJ O\u2019Connell","year":"1997","unstructured":"O\u2019Connell, M. J., Raleigh, J. M., Verkade, H. M. & Nurse, P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. \n                           16, 545\u2013554 (1997).","journal-title":"EMBO J."},{"key":"1850_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.277.5331.1501","volume":"277","author":"CY Peng","year":"1997","unstructured":"Peng, C.-Y. et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on Serine-216. Science \n                           277, 1501\u20131505 (1997).","journal-title":"Science"},{"key":"1850_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.277.5331.1497","volume":"277","author":"Y Sanchez","year":"1997","unstructured":"Sanchez, Y. et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science \n                           277, 1497\u20131501 (1997).","journal-title":"Science"},{"key":"1850_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ncb1337","volume":"8","author":"A Jazayeri","year":"2006","unstructured":"Jazayeri, A. et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. \n                           8, 37\u201345 (2006).","journal-title":"Nat. Cell Biol."},{"key":"1850_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ncb1212","volume":"7","author":"CS Sorensen","year":"2005","unstructured":"Sorensen, C. S. et al. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol. \n                           7, 195\u2013201 (2005).","journal-title":"Nat. Cell Biol."},{"key":"1850_CR10","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1158\/0008-5472.CAN-06-3545","volume":"67","author":"L Verlinden","year":"2007","unstructured":"Verlinden, L. et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor \/progesterone receptor \/HER-2 breast carcinomas. Cancer Res. \n                           67, 6574\u20136581 (2007).","journal-title":"Cancer Res."},{"key":"1850_CR11","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1128\/MCB.26.8.3319-3326.2006","volume":"26","author":"E Petermann","year":"2006","unstructured":"Petermann, E. et al. Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol. Cell. Biol. \n                           26, 3319\u20133326 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"1850_CR12","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/sj.emboj.7601714","volume":"26","author":"A Maya-Mendoza","year":"2007","unstructured":"Maya-Mendoza, A., Petermann, E., Gillespie, D. A., Caldecott, K. W. & Jackson, D. A. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J. \n                           26, 2719\u20132731 (2007).","journal-title":"EMBO J."},{"key":"1850_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4161\/cc.2.6.503","volume":"2","author":"L Carrassa","year":"2003","unstructured":"Carrassa, L., Broggini, M., Vikhanskaya, F. & Damia, G. Characterization of the 5\u2019flanking region of the human Chk1 gene: identification of E2F1 functional sites. Cell Cycle \n                           2, 604\u2013609 (2003).","journal-title":"Cell Cycle"},{"key":"1850_CR14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1101\/gad.14.12.1439","volume":"14","author":"H Takai","year":"2000","unstructured":"Takai, H. et al. Aberrant cell cycle checkpoint function and early embryonic death in Chk1\n                    \u2212\/\u2212\n                   mice. Genes Dev. \n                           14, 1439\u20131447 (2000).","journal-title":"Genes Dev."},{"key":"1850_CR15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1101\/gad.840500","volume":"14","author":"Q Liu","year":"2000","unstructured":"Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G2\/M DNA damage checkpoint. Genes Dev. \n                           14, 1448\u20131459 (2000).","journal-title":"Genes Dev."},{"key":"1850_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molcel.2006.06.013","volume":"23","author":"A Peschiaroli","year":"2006","unstructured":"Peschiaroli, A. et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell \n                           23, 319\u2013329 (2006).","journal-title":"Mol. Cell"},{"key":"1850_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.molcel.2006.06.016","volume":"23","author":"N Mailand","year":"2006","unstructured":"Mailand, N., Bekker-Jensen, S., Bartek, J. & Lukas, J. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell \n                           23, 307\u2013318 (2006).","journal-title":"Mol. Cell"},{"key":"1850_CR18","doi-asserted-by":"publisher","first-page":"34223","DOI":"10.1074\/jbc.C109.051540","volume":"284","author":"M Enomoto","year":"2009","unstructured":"Enomoto, M. et al. Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2\/M transition. J. Biol. Chem. \n                           284, 34223\u201334230 (2009).","journal-title":"J. Biol. Chem."},{"key":"1850_CR19","doi-asserted-by":"publisher","first-page":"20752","DOI":"10.1073\/pnas.0806917106","volume":"105","author":"D Wilsker","year":"2008","unstructured":"Wilsker, D., Petermann, E., Helleday, T. & Bunz, F. Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc. Natl Acad. Sci. USA \n                           105, 20752\u201320757 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1850_CR20","doi-asserted-by":"publisher","first-page":"11964","DOI":"10.1073\/pnas.0604987103","volume":"103","author":"J Tang","year":"2006","unstructured":"Tang, J., Erikson, R. L. & Liu, X. Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1). Proc. Natl Acad. Sci. USA \n                           103, 11964\u201311969 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1850_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.devcel.2007.01.003","volume":"12","author":"G Zachos","year":"2007","unstructured":"Zachos, G. et al. Chk1 is required for spindle checkpoint function. Dev. Cell \n                           12, 247\u2013260 (2007).","journal-title":"Dev. Cell"},{"key":"1850_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/sj.onc.1209056","volume":"25","author":"A Krystyniak","year":"2006","unstructured":"Krystyniak, A., Garcia-Echeverria, C., Prigent, C. & Ferrari, S. Inhibition of Aurora A in response to DNA damage. Oncogene \n                           25, 338\u2013348 (2006).","journal-title":"Oncogene"},{"key":"1850_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccr.2004.06.015","volume":"6","author":"MH Lam","year":"2004","unstructured":"Lam, M. H., Liu, Q., Elledge, S. J. & Rosen, J. M. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell \n                           6, 45\u201359 (2004).","journal-title":"Cancer Cell"},{"key":"1850_CR24","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1038\/onc.2010.163","volume":"29","author":"T Fishler","year":"2010","unstructured":"Fishler, T. et al. Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene \n                           29, 4007\u20134017 (2010).","journal-title":"Oncogene"},{"key":"1850_CR25","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1038\/emboj.2010.218","volume":"29","author":"H Niida","year":"2010","unstructured":"Niida, H. et al. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J. \n                           29, 3558\u20133570 (2010).","journal-title":"EMBO J."},{"key":"1850_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.leu.2403571","volume":"19","author":"F Tort","year":"2005","unstructured":"Tort, F. et al. Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leukemia \n                           19, 112\u2013117 (2005).","journal-title":"Leukemia"},{"key":"1850_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10689-010-9360-7","volume":"9","author":"S Solyom","year":"2010","unstructured":"Solyom, S., Pylkas, K. & Winqvist, R. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families. Fam. Cancer \n                           9, 537\u2013540 (2010).","journal-title":"Fam. Cancer"},{"key":"1850_CR28","first-page":"7727","volume":"61","author":"A Menoyo","year":"2001","unstructured":"Menoyo, A. et al. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res. \n                           61, 7727\u20137730 (2001).","journal-title":"Cancer Res."},{"key":"1850_CR29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1172\/JCI61380","volume":"122","author":"J Hong","year":"2012","unstructured":"Hong, J. et al. CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. J. Clin. Invest. \n                           122, 2165\u20132175 (2012).","journal-title":"J. Clin. Invest."},{"key":"1850_CR30","doi-asserted-by":"publisher","first-page":"ra90","DOI":"10.1126\/scisignal.aac9704","volume":"9","author":"L David","year":"2016","unstructured":"David, L. et al. CHK1 as a therapeutic target to bypass chemoresistance in AML. Sci. Signal. \n                           9, ra90 (2016).","journal-title":"Sci. Signal."},{"key":"1850_CR31","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1158\/1078-0432.CCR-11-1198","volume":"17","author":"A Hoglund","year":"2011","unstructured":"Hoglund, A. et al. Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells. Clin. Cancer Res.\n                           17, 7067\u20137079 (2011).","journal-title":"Clin. Cancer Res."},{"key":"1850_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molonc.2011.07.002","volume":"5","author":"LI Toledo","year":"2011","unstructured":"Toledo, L. I., Murga, M. & Fernandez-Capetillo, O. Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs. Mol. Oncol. \n                           5, 368\u2013373 (2011).","journal-title":"Mol. Oncol."},{"key":"1850_CR33","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/onc.2011.358","volume":"31","author":"PT Ferrao","year":"2012","unstructured":"Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W. & McArthur, G. A. Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells. Oncogene \n                           31, 1661\u20131672 (2012).","journal-title":"Oncogene"},{"key":"1850_CR34","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.18632\/oncotarget.2720","volume":"6","author":"E Derenzini","year":"2015","unstructured":"Derenzini, E. et al. Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma. Oncotarget \n                           6, 6553\u20136569 (2015).","journal-title":"Oncotarget"},{"key":"1850_CR35","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/nsmb.2189","volume":"18","author":"M Murga","year":"2011","unstructured":"Murga, M. et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. \n                           18, 1331\u20131335 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1850_CR36","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.celrep.2016.12.031","volume":"17","author":"K Sanjiv","year":"2016","unstructured":"Sanjiv, K. et al. Cancer-specific synthetic lethality between ATR and CHK1 kinase activities. Cell Rep. \n                           17, 3407\u20133416 (2016).","journal-title":"Cell Rep."},{"key":"1850_CR37","doi-asserted-by":"crossref","unstructured":"Lindner, S. E. et al. The miR-15 family reinforces the transition from proliferation to differentiation in pre-B cells. EMBO Rep. (2017). 18, 1604-1617.","DOI":"10.15252\/embr.201643735"},{"key":"1850_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1101\/gr.201501","volume":"12","author":"R Hoffmann","year":"2002","unstructured":"Hoffmann, R., Seidl, T., Neeb, M., Rolink, A. & Melchers, F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. \n                           12, 98\u2013111 (2002).","journal-title":"Genome Res."},{"key":"1850_CR39","doi-asserted-by":"publisher","first-page":"14943","DOI":"10.1073\/pnas.96.26.14943","volume":"96","author":"S Ogilvy","year":"1999","unstructured":"Ogilvy, S. et al. Constitutive bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl Acad. Sci. USA \n                           96, 14943\u201314948 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1850_CR40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature \n                           318, 533\u2013538 (1985).","journal-title":"Nature"},{"key":"1850_CR41","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2013.371","volume":"33","author":"KR Greenow","year":"2014","unstructured":"Greenow, K. R., Clarke, A. R., Williams, G. T. & Jones, R. Wnt-driven intestinal tumourigenesis is suppressed by Chk1 deficiency but enhanced by conditional haploinsufficiency. Oncogene \n                           33, 4089\u20134096 (2014).","journal-title":"Oncogene"},{"key":"1850_CR42","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1101\/gad.1940210","volume":"24","author":"V Labi","year":"2010","unstructured":"Labi, V. et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev. \n                           24, 1602\u20131607 (2010).","journal-title":"Genes Dev."},{"key":"1850_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer. Cell \n                           149, 22\u201335 (2012).","journal-title":"Cell"},{"key":"1850_CR44","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1073\/pnas.0806671106","volume":"106","author":"S Peddibhotla","year":"2009","unstructured":"Peddibhotla, S., Lam, M. H., Gonzalez-Rimbau, M. & Rosen, J. M. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis. Proc. Natl Acad. Sci. USA \n                           106, 5159\u20135164 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1850_CR45","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cell.2015.01.042","volume":"160","author":"J Montero","year":"2015","unstructured":"Montero, J. et al. Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell \n                           160, 977\u2013989 (2015).","journal-title":"Cell"},{"key":"1850_CR46","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/onc.2011.326","volume":"31","author":"LM Tho","year":"2012","unstructured":"Tho, L. M., Libertini, S., Rampling, R., Sansom, O. & Gillespie, D. A. Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis. Oncogene \n                           31, 1366\u20131375 (2012).","journal-title":"Oncogene"},{"key":"1850_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1084\/jem.20112147","volume":"209","author":"AJ Lopez-Contreras","year":"2012","unstructured":"Lopez-Contreras, A. J., Gutierrez-Martinez, P., Specks, J., Rodrigo-Perez, S. & Fernandez-Capetillo, O. An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. J. Exp. Med. \n                           209, 455\u2013461 (2012).","journal-title":"J. Exp. Med."},{"key":"1850_CR48","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.0611584104","volume":"104","author":"K Zaugg","year":"2007","unstructured":"Zaugg, K. et al. Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc. Natl Acad. Sci. USA \n                           104, 3805\u20133810 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1850_CR49","doi-asserted-by":"publisher","first-page":"e8581","DOI":"10.1371\/journal.pone.0008581","volume":"5","author":"NC Boles","year":"2010","unstructured":"Boles, N. C., Peddibhotla, S., Chen, A. J., Goodell, M. A. & Rosen, J. M. Chk1 haploinsufficiency results in anemia and defective erythropoiesis. PLoS ONE \n                           5, e8581 (2010).","journal-title":"PLoS ONE"},{"key":"1850_CR50","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/onc.2008.482","volume":"28","author":"KR Greenow","year":"2009","unstructured":"Greenow, K. R., Clarke, A. R. & Jones, R. H. Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene \n                           28, 1443\u20131453 (2009).","journal-title":"Oncogene"},{"key":"1850_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.289728.116","volume":"31","author":"LL Fava","year":"2017","unstructured":"Fava, L. L. et al. The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev. \n                           31, 34\u201345 (2017).","journal-title":"Genes Dev."},{"key":"1850_CR52","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.1073\/pnas.0605944103","volume":"103","author":"E Hobeika","year":"2006","unstructured":"Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl Acad. Sci. USA \n                           103, 13789\u201313794 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01850-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01850-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01850-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T23:13:48Z","timestamp":1671750828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01850-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01850-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1697"}}